Clinical utility of EUS-guided fine-needle aspiration of mediastinal masses in the absence of known pulmonary malignancy

Benedict M. Devereaux, Julia Kim LeBlanc, Edward Yousif, Kenneth Kesler, Jo Ann Brooks, Praveen Mathur, Alan Sandler, John Chappo, Glen A. Lehman, Stuart Sherman, Frank Gress, Donato Ciaccia

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background: Mediastinal masses represent a diagnostic challenge because of their proximity to numerous critical structures, difficulty of access for tissue sampling, and myriad potential pathologic etiologies. A large, single-center experience with EUS-guided fine-needle aspiration (EUSFNA) in the diagnosis of non-lung cancer-related mediastinal masses is presented. Methods: An EUS database was reviewed and all cases of mediastinal mass or lymphadenopathy encountered between 1994 and 1999 were included. Final diagnoses were determined by EUS-FNA cytology and clinical follow-up. Results: Forty-nine patients were identified (27 women, 22 men; mean age 58.1 years, range 30-89 years). A malignant process was diagnosed in 22 cases (45%) and a benign process in 24 (49%). The EUS-FNA specimen was nondiagnostic in 3 cases (6%). An accurate diagnosis was made in 46 of the 49 patients (94%). No complication was noted. Conclusions: EUS-FNA is a minimally invasive technique that facilitates detection and tissue sampling of mediastinal masses. It is a safe procedure that can be performed with the patient under conscious sedation in an outpatient setting.

Original languageEnglish (US)
Pages (from-to)397-401
Number of pages5
JournalGastrointestinal endoscopy
Volume56
Issue number3
DOIs
StatePublished - Jan 1 2002

Fingerprint

Endoscopic Ultrasound-Guided Fine Needle Aspiration
Fine Needle Biopsy
Lung
Mediastinal Neoplasms
Conscious Sedation
Neoplasms
Cell Biology
Outpatients
Databases

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Gastroenterology

Cite this

Clinical utility of EUS-guided fine-needle aspiration of mediastinal masses in the absence of known pulmonary malignancy. / Devereaux, Benedict M.; LeBlanc, Julia Kim; Yousif, Edward; Kesler, Kenneth; Brooks, Jo Ann; Mathur, Praveen; Sandler, Alan; Chappo, John; Lehman, Glen A.; Sherman, Stuart; Gress, Frank; Ciaccia, Donato.

In: Gastrointestinal endoscopy, Vol. 56, No. 3, 01.01.2002, p. 397-401.

Research output: Contribution to journalArticle

Devereaux, Benedict M. ; LeBlanc, Julia Kim ; Yousif, Edward ; Kesler, Kenneth ; Brooks, Jo Ann ; Mathur, Praveen ; Sandler, Alan ; Chappo, John ; Lehman, Glen A. ; Sherman, Stuart ; Gress, Frank ; Ciaccia, Donato. / Clinical utility of EUS-guided fine-needle aspiration of mediastinal masses in the absence of known pulmonary malignancy. In: Gastrointestinal endoscopy. 2002 ; Vol. 56, No. 3. pp. 397-401.
@article{1572efd368484fa9ae2ea6a6fc47e840,
title = "Clinical utility of EUS-guided fine-needle aspiration of mediastinal masses in the absence of known pulmonary malignancy",
abstract = "Background: Mediastinal masses represent a diagnostic challenge because of their proximity to numerous critical structures, difficulty of access for tissue sampling, and myriad potential pathologic etiologies. A large, single-center experience with EUS-guided fine-needle aspiration (EUSFNA) in the diagnosis of non-lung cancer-related mediastinal masses is presented. Methods: An EUS database was reviewed and all cases of mediastinal mass or lymphadenopathy encountered between 1994 and 1999 were included. Final diagnoses were determined by EUS-FNA cytology and clinical follow-up. Results: Forty-nine patients were identified (27 women, 22 men; mean age 58.1 years, range 30-89 years). A malignant process was diagnosed in 22 cases (45{\%}) and a benign process in 24 (49{\%}). The EUS-FNA specimen was nondiagnostic in 3 cases (6{\%}). An accurate diagnosis was made in 46 of the 49 patients (94{\%}). No complication was noted. Conclusions: EUS-FNA is a minimally invasive technique that facilitates detection and tissue sampling of mediastinal masses. It is a safe procedure that can be performed with the patient under conscious sedation in an outpatient setting.",
author = "Devereaux, {Benedict M.} and LeBlanc, {Julia Kim} and Edward Yousif and Kenneth Kesler and Brooks, {Jo Ann} and Praveen Mathur and Alan Sandler and John Chappo and Lehman, {Glen A.} and Stuart Sherman and Frank Gress and Donato Ciaccia",
year = "2002",
month = "1",
day = "1",
doi = "10.1016/S0016-5107(02)70045-X",
language = "English (US)",
volume = "56",
pages = "397--401",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Clinical utility of EUS-guided fine-needle aspiration of mediastinal masses in the absence of known pulmonary malignancy

AU - Devereaux, Benedict M.

AU - LeBlanc, Julia Kim

AU - Yousif, Edward

AU - Kesler, Kenneth

AU - Brooks, Jo Ann

AU - Mathur, Praveen

AU - Sandler, Alan

AU - Chappo, John

AU - Lehman, Glen A.

AU - Sherman, Stuart

AU - Gress, Frank

AU - Ciaccia, Donato

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Background: Mediastinal masses represent a diagnostic challenge because of their proximity to numerous critical structures, difficulty of access for tissue sampling, and myriad potential pathologic etiologies. A large, single-center experience with EUS-guided fine-needle aspiration (EUSFNA) in the diagnosis of non-lung cancer-related mediastinal masses is presented. Methods: An EUS database was reviewed and all cases of mediastinal mass or lymphadenopathy encountered between 1994 and 1999 were included. Final diagnoses were determined by EUS-FNA cytology and clinical follow-up. Results: Forty-nine patients were identified (27 women, 22 men; mean age 58.1 years, range 30-89 years). A malignant process was diagnosed in 22 cases (45%) and a benign process in 24 (49%). The EUS-FNA specimen was nondiagnostic in 3 cases (6%). An accurate diagnosis was made in 46 of the 49 patients (94%). No complication was noted. Conclusions: EUS-FNA is a minimally invasive technique that facilitates detection and tissue sampling of mediastinal masses. It is a safe procedure that can be performed with the patient under conscious sedation in an outpatient setting.

AB - Background: Mediastinal masses represent a diagnostic challenge because of their proximity to numerous critical structures, difficulty of access for tissue sampling, and myriad potential pathologic etiologies. A large, single-center experience with EUS-guided fine-needle aspiration (EUSFNA) in the diagnosis of non-lung cancer-related mediastinal masses is presented. Methods: An EUS database was reviewed and all cases of mediastinal mass or lymphadenopathy encountered between 1994 and 1999 were included. Final diagnoses were determined by EUS-FNA cytology and clinical follow-up. Results: Forty-nine patients were identified (27 women, 22 men; mean age 58.1 years, range 30-89 years). A malignant process was diagnosed in 22 cases (45%) and a benign process in 24 (49%). The EUS-FNA specimen was nondiagnostic in 3 cases (6%). An accurate diagnosis was made in 46 of the 49 patients (94%). No complication was noted. Conclusions: EUS-FNA is a minimally invasive technique that facilitates detection and tissue sampling of mediastinal masses. It is a safe procedure that can be performed with the patient under conscious sedation in an outpatient setting.

UR - http://www.scopus.com/inward/record.url?scp=0036738837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036738837&partnerID=8YFLogxK

U2 - 10.1016/S0016-5107(02)70045-X

DO - 10.1016/S0016-5107(02)70045-X

M3 - Article

C2 - 12196779

AN - SCOPUS:0036738837

VL - 56

SP - 397

EP - 401

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 3

ER -